Tuberculosis in orthotopic liver transplant patients: Increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens Academic Article uri icon

Overview

MeSH Major

  • Antitubercular Agents
  • Liver
  • Liver Transplantation
  • Postoperative Complications
  • Tuberculosis

abstract

  • Our experience reveals that orthotopic liver transplant patients have poor tolerance for conventional therapy due to inherent toxicity of these agents and their concomitant bouts of organ rejection. Our nonconventional therapy yielded remarkably good results in that six patients, all with disseminated disease, were well after mean 3.5 years of follow-up. Consideration should be given to this novel follow-up therapy in patients without cavitary pulmonary disease who develop hepatotoxicity during induction.

publication date

  • January 15, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10653382

Additional Document Info

start page

  • 64

end page

  • 9

volume

  • 69

number

  • 1